IL43562A - Pharmaceutical formulations containing allopurinol as inhibitor of xanthine oxidase - Google Patents

Pharmaceutical formulations containing allopurinol as inhibitor of xanthine oxidase

Info

Publication number
IL43562A
IL43562A IL43562A IL4356273A IL43562A IL 43562 A IL43562 A IL 43562A IL 43562 A IL43562 A IL 43562A IL 4356273 A IL4356273 A IL 4356273A IL 43562 A IL43562 A IL 43562A
Authority
IL
Israel
Prior art keywords
tablet formulation
formulation according
allopurinol
particle size
inhibitor
Prior art date
Application number
IL43562A
Other languages
English (en)
Other versions
IL43562A0 (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IL43562A0 publication Critical patent/IL43562A0/xx
Publication of IL43562A publication Critical patent/IL43562A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL43562A 1972-11-06 1973-11-05 Pharmaceutical formulations containing allopurinol as inhibitor of xanthine oxidase IL43562A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5105072A GB1445983A (en) 1972-11-06 1972-11-06 Pharmaceutical formulations

Publications (2)

Publication Number Publication Date
IL43562A0 IL43562A0 (en) 1974-03-14
IL43562A true IL43562A (en) 1976-08-31

Family

ID=10458450

Family Applications (1)

Application Number Title Priority Date Filing Date
IL43562A IL43562A (en) 1972-11-06 1973-11-05 Pharmaceutical formulations containing allopurinol as inhibitor of xanthine oxidase

Country Status (14)

Country Link
JP (1) JPS577127B2 (el)
AU (1) AU467532B2 (el)
BE (1) BE806946A (el)
CA (1) CA975297A (el)
CH (1) CH583734A5 (el)
CY (1) CY940A (el)
DE (1) DE2355204A1 (el)
FR (1) FR2205309B1 (el)
GB (1) GB1445983A (el)
HK (1) HK1278A (el)
IL (1) IL43562A (el)
KE (1) KE2807A (el)
MY (1) MY7800180A (el)
ZA (1) ZA738489B (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1499672A (en) * 1974-02-14 1978-02-01 Wellcome Found Tablet formulation
US4143129A (en) 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets
FR2608045B1 (fr) * 1986-12-12 1990-03-02 Chauvin Laboratoires Utilisation d'inhibiteurs de xanthine- oxydase, de piegeurs de radicaux libres oxygenes et de chelateurs du fer pour la fabrication d'une composition pharmaceutique destinee au traitement du glaucome et compositions pharmaceutiques destinees au traitement du glaucome

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB975850A (en) * 1955-08-10 1964-11-18 Wellcome Found Xanthine oxidase inhibitors

Also Published As

Publication number Publication date
CY940A (en) 1978-06-23
KE2807A (en) 1978-02-17
CH583734A5 (el) 1977-01-14
AU467532B2 (en) 1975-12-04
DE2355204A1 (de) 1974-05-16
FR2205309B1 (el) 1976-04-09
JPS49133517A (el) 1974-12-21
CA975297A (en) 1975-09-30
HK1278A (en) 1978-01-13
JPS577127B2 (el) 1982-02-09
IL43562A0 (en) 1974-03-14
GB1445983A (en) 1976-08-11
ZA738489B (en) 1975-02-26
AU6217773A (en) 1975-05-08
BE806946A (fr) 1974-05-06
MY7800180A (en) 1978-12-31
FR2205309A1 (el) 1974-05-31

Similar Documents

Publication Publication Date Title
GB1381588A (en) Process for the preparation of porous tablets
DE3461054D1 (en) Divisible tablet with sustained release of the active ingredient, and process for its production
FI872577A (fi) Menetelmä terapeuttisesti käyttökelpoisten, hydrofobisen tai niukkaliukoisen aineen mikronisoitujen, hydrofilisoitujen hiukkasten valmistamiseksi
MY101847A (en) Composition for solid pharmaceutical preparations of active vitamins d 3 and process for preparation thereof.
AU1729297A (en) Solid formulations containing trehalose
IL43562A (en) Pharmaceutical formulations containing allopurinol as inhibitor of xanthine oxidase
CA1018890A (en) Hard pharmaceutical tablets containing orally active penicillin or cephalosporin and heavy magnesium carbonate
GB1457546A (en) Pharmaceutical preparations comprising cephalosporin derivatives
GB1202148A (en) Pharmaceutical compositions
GB1363047A (en) Pyrimidine derivative process for its preparation and its use as a medicament
GB1315177A (en) Antibiotic and process for preparing same
CA945473A (en) PROCESS FOR STABILIZATION OF A COMPOSITION OF 2.alpha.,3.alpha.-EPITHIO-ANDROSTANES AND COMPOSITION OBTAINED THEREBY
ZA712798B (en) New,pharmaceutically active 2,3-diazabicyclo(5.4.0)undecapentaene derivative and process for preparing same
IE39557L (en) TABLETS CONTAINING ß-LACTAM ANTIBIOTICS AND UREA
GB1391554A (en) Pharmaceutical compositions and process for their preparation
JPS5247984A (en) Stabilization of elastase
GB1330545A (en) Pharmaceutical preparations
CA921924A (en) Process for the preparation of compounds having a 2,3,5,6-tetrahydro-imidazo(2,1-b)thiazole ring system
GB1360032A (en) 2-thio-5-azocytosine and its nucleosides
CA846170A (en) PROCESS FOR THE PREPARATION OF 7-(.alpha.-(4-PYRIDYLTHIO) ACETAMIDO) CEPHALOSPORINS
IE34501L (en) Sulphonyl-imidazolidines
IE34386L (en) Acetylsalicylic acid-containing composition
GB823914A (en) Improvements in penicillin-sulphonamide tablets
JPS5259650A (en) Preparation of granular composite stabilizer for polyvinyl chloride
GB1311444A (en) Cyclopentyl urea and process for its production